Optical coherence tomography angiography for monitoring the treatment of neovascular age‐related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Optical Coherence Tomography Angiography for Monitoring the Treatment of Neovascular Age‐related Macular Degeneration." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437416/2/repview. Accessed 26 May 2024.
Optical coherence tomography angiography for monitoring the treatment of neovascular age‐related macular degeneration. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437416/2/repview. Accessed May 26, 2024.
Optical coherence tomography angiography for monitoring the treatment of neovascular age‐related macular degeneration. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437416/2/repview
Optical Coherence Tomography Angiography for Monitoring the Treatment of Neovascular Age‐related Macular Degeneration [Internet]. In: Cochrane Abstracts. [cited 2024 May 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437416/2/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Optical coherence tomography angiography for monitoring the treatment of neovascular age‐related macular degeneration
ID - 437416
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437416/2/repview
DB - Evidence Central
DP - Unbound Medicine
ER -